Press Release

XtalPi intelligent digital drug discovery and development

AI Biotech XtalPi Closes Series B Round Funding from Sequoia China, Google, and Tencent

Leading technology investors back Intelligent Digital Drug Discovery and Development startup for faster, smarter pharmaceutical research     CAMBRIDGE, Mass., SHENZHEN, China – XtalPi Inc., a computation-driven pharmaceutical technology company, announced today that it has closed a Series B funding round of 15 million USD led by Sequoia...

Read More

XtalPi and AMRI’s SSCI Enter into Joint Research Agreement to Apply Computational Technologies to Solid-Form Pharmaceutical Research Challenges

  Boston, Mass., (July 21, 2017) –XtalPi Inc., a pharmaceutical technology company offering intelligent digital drug development solutions to empower more efficient pharmaceutical research, is joining forces with AMRI SSCI, LLC (SSCI), a division of Albany Molecular Research, Inc. (AMRI), to identify solid forms of small...

Read More